Skip to main content
Mark Pegram, MD, Oncology, Palo Alto, CA, Stanford Health Care

MarkDanielPegramMD

Oncology Palo Alto, CA

Professor, Medicine, Stanford University Sch of Med

Are you Dr. Pegram?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Connect with colleagues in the same hospital or clinic
    You already have 64 invites waiting!
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Summary

  • Dr. Mark Pegram, MD is an oncologist in Palo Alto, California. He is currently licensed to practice medicine in California, Florida, and Texas. He is affiliated with Stanford Health Care and is a Professor at Stanford University Sch of Med.

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1990 - 1993
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Internal Medicine, 1986 - 1989
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 1986

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1989 - 2024
  • FL State Medical License
    FL State Medical License 2008 - 2012
  • TX State Medical License
    TX State Medical License 1989 - 1990
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2011-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2007, 2010-2013
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Meet 7 Femtech Companies Innovating in the Area of Ovarian Health, Breast and Gynecological Cancers
    Meet 7 Femtech Companies Innovating in the Area of Ovarian Health, Breast and Gynecological CancersMarch 16th, 2022
  • Clinical Picture Brightens for HER2+ Breast Cancer with Brain Metastases
    Clinical Picture Brightens for HER2+ Breast Cancer with Brain MetastasesMarch 7th, 2022
  • Cedars-Sinai, Rubedo Partner to Develop Targeted IPF Treatments
    Cedars-Sinai, Rubedo Partner to Develop Targeted IPF TreatmentsJune 8th, 2021
  • Join now to see all

Hospital Affiliations